Serratus Posterior Plane Block vs Erector Spine Plane Block

NCT ID: NCT07021131

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-01

Study Completion Date

2026-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analgesia related to the administration of local anesthetic solution into the fascia of erector spinae muscle is mediated by the effect of local anesthetic on the posterior and lateral branches of the anterior part of the spinal nerve. Comparable analgesic efficiency after the administration of both nerve blocks would reject the widespread theory of the paravertebral site of effect of the local anesthetic in ESPB.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Regional Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spinae plane block

Patients undergoing VATS with the use of continuous peripheral nerve block type A.

Group Type NO_INTERVENTION

No interventions assigned to this group

Serratus Posterior Plane Block

Patients undergoing general anaesthesia with continuous peripheral block type B.

Group Type EXPERIMENTAL

new type of peripheral block Serratus Posterior Plane Block

Intervention Type PROCEDURE

Intervention will be Serratus Posterior Plane Block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

new type of peripheral block Serratus Posterior Plane Block

Intervention will be Serratus Posterior Plane Block.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patiens undergoing VATS-surgery

Exclusion Criteria

* Age \< 20 years
* Body Mass Index \>35 kg/m2
* Technical difficulties with the nerve block administration and/or subsequent bolus application
* Abnormal course of the surgery (e.g. conversion to thoracotomy) or the postoperative phase (e.g. surgical revision of the chest)
* Patient's refusal
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel Nalos

senior researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Miroslava Korfova

Role: PRINCIPAL_INVESTIGATOR

Krajská zdravotní, a.s. - Masarykova nemocnice v Ústí nad Labem, o.z.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Krajská zdravotní, a.s. - Masarykova nemocnice v Ústí nad Labem, o.z.

Ústí nad Labem, Ústecký kraj, Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel Nalos

Role: CONTACT

+420737230792

Ondrej Maly

Role: CONTACT

+420774145512

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SERRATUS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.